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Coronal mode ultrasound guided
hemodialysis cannulation: A pilot
randomized comparison with standard
cannulation technique
Lalathaksha KUMBAR, Vivek SOI, Elizabeth ADAMS, Cheryl BROWN DEACON,
Mohamed ZIDAN, Jerry YEE
Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, Michigan, USA

Abstract
Background: Inﬁltrations from cannulation result in signiﬁcant morbidity including loss of hemodialysis (HD) vascular access (VA). Cannulation is dependent on personnel skill and VA characteristics. Surface marking of VA lacks real-time information and traditional ultrasound (US) devices are
C (Analogic Ultrasound, Peabody, MA,
large, expensive, requiring skilled operators. Sonic WindowV
USA) is a coronal mode ultrasound device (CMUD) approved for VA cannulation.
Methods: Single center randomized, prospective pilot study comparing handheld US-guided cannulation of new arteriovenous ﬁstula (AVF) to standard cannulation practices. Patients with end
stage renal disease (ESRD) on in-center HD who had a new AVF cleared for cannulation and dialysis
were enrolled. Patients with new AVF received either standard cannulation (control group) or image
guidance using CMUD (study group) for 3 weeks. Ultrasound characteristics of VA, cannulation
practices and complications end points were obtained.
Results: An inﬁltration rate of 9.7% was noted during the study. Slightly lower odds ratio (OR) of
inﬁltration was observed in the study group (OR 0.94, 95% CI: 0.26–3.41, P value 5 0.93). Study
group yielded longer time for assessment (101.8 6 80.2 vs. 22.3 6 22.5 seconds, P 5 < 0.001),
increased cannulation time (41.1 6 70.6 vs. 25.0 6 27.9 seconds, P 5 0.04), and increased patient
satisfaction (94.6% vs. 82%, P 5 0.04) compared to control group. Number of cannulation attempts,
needle size, arterial or venous needle insertion, and tourniquet usage between groups were not
statistically different.
Conclusion: Handheld ultrasound is a safe and useful aid in cannulation of dialysis access.
Key words: Arteriovenous ﬁstula, cannulation, handheld device, hemodialysis, inﬁltration, ultrasound guidance
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INTRODUCTION
The arteriovenous fistula (AVF) is the preferred form of
vascular access (VA) for hemodialysis.1 Transformation
from “Fistula First Breakthrough Initiative” to “Fistula First
Catheter Last Strategy” illustrates a dual front battle in
obtaining a reliable dialysis access. AVF maturation failure
has been indicated as a hindrance in achieving high fistula
prevalence.2 Secondary procedures to improve AVF maturation are growing.3 Less than 10% of fistulae are successfully cannulated with two needles and reported infiltration
rates are high (2.98 times more likely to have infiltration
in an AVF of 6 months or less vintage).4,5 Infiltration risk
is highest in the early cannulation phase of a new AVF.
Infiltration episodes lead to more diagnostic tests, costly
interventions and prolongation of catheter use.
The method of access cannulation has not seen major
changes in decades. The current techniques depend upon
tactile sensation. Skin marking including tattoo or photographic image are frequently used to aid cannulators. Surface markings lack real-time information and are not
well-studied.6 A possible solution could be utilization of
ultrasound guidance for AVF cannulation. In 2002, the
Agency for Healthcare Research and Quality first proposed
that ultrasound guidance for central line insertion as an
evidence-based safety solution.7 In 2011, the Centers for
Disease Control and Prevention also listed the use of ultrasound as a safety solution to prevent catheter-related bloodstream infection.8 Ultrasound guided access of both the
artery and vein in other procedures has demonstrated superiority over physical examination.9,10 Although usage of
ultrasound-guidance for cannulation of veins is now well
accepted in various procedures, its utilization data during
cannulation of dialysis access is minimal.
Value of ultrasound assisted AVF cannulation is a function of quality and cost. Dialysis access cannulation
encounters certain unique challenges. Dialysis technicians
or nurses are frequently trained on-the job. Patients are
dialyzed in shifts using special chairs with dialysis
machines in close proximity. Any delay in patient care
leads to ripple effects on work flow, patient care, and staff
management. Infection control practices in hemodialysis
centers are heavily regulated and closely scrutinized. Traditional ultrasound machines have a relatively large footprint making it clumsy to employ them routinely for
access cannulation. It requires a certain level of staff competency to operate the device and can be a challenge in
meeting regulatory requirements for infection control of
devices. These and other factors have led to poor utilization of ultrasonography for in-center hemodialysis access
care.
24

The Sonic Window (Analogic Ultrasound, Peabody,
MA, USA) is a novel C mode handheld ultrasound device
approved as a VA cannulation aid. It is portable with a
small footprint and has smart touch technology for single
hand use. The device has been predominantly used for
peripheral intravenous line placement and has not yet
been evaluated for guiding cannulation of dialysis access
on a systematic basis in an in-center hemodialysis setting.
A theoretical concern would be the effect of ultrasound
usage in dialysis centers on its workflow. Staff training and
time involved in preparation, usage, and maintenance
could impact the daily activities of dialysis units. Improper
use of an US device can result in complications and loss of
access. Anecdotal incidental usage of conventional US
devices for patient with difficult access has been reported
in the past, but continuation as a standard of practice for
cannulation has not been evaluated. We propose that C
mode ultrasonography can be utilized on a routine basis
during cannulation of new AVFs at in-center hemodialysis
units with no increased risk of complications.

SUBJECTS AND METHODS
Study design and eligibility criteria
We designed a randomized, prospective pilot study comparing handheld ultrasound guided cannulation of AVF
to standard cannulation practices in patients with end
stage renal disease (ESRD). A pilot study is performed to
examine roles, feasibility, recruitment, retention, assessment, and implementation of a novel therapy or intervention. It is not intended to test a hypothesis.11 Although,
no set sample size has been recommended, literature suggests sample size of 10–30 to 10% of the intended sample.12 This was a proof of concept study to demonstrate
that a handheld ultrasound device can be used as a dialysis access cannulation aid. The study was not designed to
show a noninferiority or superiority at this level. Cost
effectiveness would require further studies to evaluate
effect and cost associated with downstream complications
arising from an infiltration.
Ten ESRD patients with new AVF cleared for cannulation were approached to participate in the study. We
assumed 5 patients in each arm with maximum of 18 cannulations in 9 dialysis sessions (each dialysis requires two
needle cannulations) will yield up-to 90 cannulations per
study arm. New AVF were chosen as they are more prone
to needle infiltration and significant consequent morbidity. Clearance for fistula use was provided by vascular surgery as per site specific practices (physical examination
Hemodialysis International 2018; 22:23–30
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Figure 1 (a) Representational image of the device, (b) standard preparation for cannulation of fistula, and (c) image showing
the fistula course and depth. [Color figure can be viewed at wileyonlinelibrary.com]

alone). Pre-clearance ultrasound evaluation of access was
not the standard of practice. Two handheld ultrasound
devices were provided by the sponsor for study. The
patients were randomized to either the standard cannulation protocol (control group) or to the real-time ultrasound guided cannulation group (study group). The
study period (fistula initiation phase) included 3 weeks
from first cannulation or a total of 9 hemodialysis sessions
per patient whichever occurred first, with a 3-month follow-up period. Four dialysis personnel were provided
with up to 3 hours of simulated training in operation of
the device followed by competency evaluation. The study
protocol was approved by institutional review board and
registered in clinicaltrials.gov (NCT02814721). Written
informed consent was obtained from all patients at
screening.

The study protocol involved similar titration of needle
size over a 3-week period, except that a pre-cannulation

Protocol description
The standard cannulation protocol of the center was
defined as using 17 gauge needles for the first 3 dialysis sessions, followed by 16 gauge for the next 3, and 15 gauge
for subsequent sessions. Fistula initiation was considered as
successful if fistula was used with two needles consecutively
during the first three week. All new fistulae in the standard
protocol were cannulated by personnel defined as members
of the specialist cannulation team of the dialysis center. Needle direction could be in the direction of blood flow or in
an opposing configuration.
Hemodialysis International 2018; 22:23–30

Figure 2 Image showing suggested needle size and vessel
luminal diameter. [Color figure can be viewed at wileyonlinelibrary.com]
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5–10 minutes, 10–15 minutes, or above 15 minutes; and
9) infiltration (during cannulation or ecchymosis over
access at subsequent dialysis session): classified into
major (cannulation abandoned for that dialysis session) or
minor (further successful attempts in same session).
Access outcomes at the end of initiation phase and
3-month follow-up included 1) success of fistula initiation; 2) fistula rest due to major infiltration; 3) continued
catheter use; 4) catheter removal date; 5) catheter-related
complications; 6) access related hospitalizations and procedures; and 7) missed dialysis sessions.

Statistical methodology

Figure 3 Image showing needle track while performing
real time cannulation. [Color figure can be viewed at
wileyonlinelibrary.com]

evaluation of the fistula was performed using the Sonic
Window device. The device was used to evaluate and
identify site of cannulation (Figure 1). Use of real-time
guidance was at the discretion of cannulators (Figures 2
and 3). Four dialysis personnel trained in device use performed all cannulations in the study group. The device
was disinfected between uses with hydrogen peroxide disinfectant wipes and covered with transparent adhesive
film to avoid direct contact with the patient. Special sterile
ultrasound gel packs were provided by the company for
use with real-time guided cannulation. Device-trained
cannulators were also allowed to perform cannulation in
standard group using standard protocol if staffing requirements demanded.
Collected data included age, gender, body mass index,
diabetes mellitus, hypertension, peripheral vascular disease, coronary artery disease, tunneled cuffed dialysis
catheter insertion, removal, complications, VA creation,
use, and interventions. Cannulation data included 1) precannulation real-time ultrasound parameters in the study
arm: depth from skin, needle size, and use of real-time vs.
marking only ultrasound guidance; 2) pre-cannulation
assessment time (recorded using a stop clock): classified
as < 3 minutes, 3–5 minutes, 5–10 minutes, or > 10
minutes; 3) cannulation attempts; 4) reason for failure to
cannulate; 5) dialysis at expected blood flow; 6) pain
score per patient; 7) staff comfort; 8) cannulation time
(measured from preparing the arm for ultrasound evaluation to actual cannulation): classified as under 5 minutes,
26

We compared both baseline factors as well as 3-month
follow-up data between the treatment and control arms
using Mann-Whitney tests for continuous variables and
Fisher’s exact test for categorical variables. Fisher’s exact
test was chosen for categorical variables because the small
number of recruited patients meant low expected counts
and the assumptions of the chi-square test were not met.
We assessed the number of days from first cannulation to
catheter removal between the treated and control arms
using a Mann-Whitney test. Due to the larger number of
cannulations, we used Mann-Whitney tests to compare
continuous variables and chi-square tests to compare categorical variables between the treatment and control
arms. The ratio of total infiltrations between the treatment
and control arms was modeled using generalized estimating equations modeling, and the results are displayed in
terms of an odds ratio.

RESULTS
We began with 10 patients; however, 1 patient was
excluded due to protocol violation. Final sample size was
9 patients: 5 patients in the study arm and 4 patients in
the control arm. Nine of the AVF were created by a single
vascular surgeon. Five patients in study arm had 74 cannulations and 4 patients in the control arm had data for
51 cannulations. The difference in cannulations arise
from episodes of early infiltrations in the control group
leading to fistula rest. Baseline characteristics of the randomized patients are shown in Table 1. No difference in
baseline characteristics were noted. Three brachiobasilic
transposed fistulae and two brachiocephalic fistulae were
in the study group and the control group had all brachiobasilic fistulae. Left upper extremity was predominantly
used for access in both groups with none of the patients
had an ipsilateral catheter. All patients were using catheters prior to fistula initiation with no difference in catheter
Hemodialysis International 2018; 22:23–30
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Table 1 Baseline characteristics and access outcomes at initiation phase

Age (years)
Body mass index
Male
Diabetes mellitus
Hypertension
Coronary artery disease
Access laterality left
Catheter days prior to fistula usage (days)
Fistula age prior to usage (days 6 SD)
Successful fistula initiation
Fistula rested
Hospitalizations due to fistula complications

Study (N 5 5)

Control (N 5 4)

P value

66.0 (57.0–70.0)
23.5 (23.0–32.1)
3 (60.0%)
3 (60.0%)
5 (100.0%)
1 (20.0%)
4 (80.0%)
220
114.4 6 49.7
4 (80.0%)
1 (20.0%)
0 (0.0%)

52.5 (32.5–67.5)
23.7 (22.3–25.1)
2 (50.0%)
2 (50.0%)
4 (100.0%)
2 (50.0%)
3 (75.0%)
234.3
64.5 6 31
2 (50.0%)
2 (50.0%)
1 (25.0%)

0.64
0.90
0.48
0.48
—
0.52
0.42
0.42
0.52
0.34
0.44

SD 5 standard deviation; TCC 5 tunnel cuffed catheter.

days (220 vs. 234 days). Fistulae in the study group had
longer maturation days compared to the control group;
however, the results were not statistically significant
(114.4 6 49.7 vs. 64.5 6 31 days, P 5 0.42).
The principal outcome measure of infiltration episodes
was not different between the groups. Overall, 12 infiltrations (9.7%) were noted. There were 112 (90.3%) cannulations without an infiltration. Data for one cannulation in
control group was lacking. Overall, 7 out of 74 (9.5%)
cannulations in the study group had an infiltration compared to 5 out of 50 cannulations (10.0%) in the control
group (odds ratio 0.94, 95% CI: 0.26–3.41, P 5 0.93).
Lower odds of infiltration in the study group was noted
without statistical significance. A higher percentage of
major infiltration episodes in the study group (6.8%)
were noted compared to the control group (4.0%) lacking
statistical signficance (P 5 0.70). Time to first infiltration
varied from 0 to 14 days (median 7 days). Postinfiltration accesses were rested in two subjects in the
control group and one in the study group.

Cannulation measures
Among US aided cannulations, the median fistula depth
(skin to proximal wall of the fistula) was noted to be 5
mm 6 1.7 mm and with a suggested needle size of 13.6
gauge 6 1.7. Real-time guidance was used in 61% of cannulations in the study group with the rest using the
device for needle site marking only. Cannulators in the
study group were given latitude to choose between real
time guided cannulation vs. using device to mark optimal
cannulation site depending on their comfort level with
the device. Two cannulations did not have data recorded
for depth, mark only vs. real-time and three cannulations
Hemodialysis International 2018; 22:23–30

lacked suggested needle size. Predictably US guided cannulations took a longer time for assessment (101.8 6 80.2
vs. 22.3 6 22.5 seconds, P 5 < 0.001) and cannulation
(41.1 6 70.6 vs. 25.0 6 27.9 seconds, P 5 0.04) compared to standard cannulation practices. There was no
statistical difference in the number of cannulation
attempts, needle size, arterial, or venous needle insertion
and tourniquet usage between the groups (Table 2). The
study group had a higher average achieved blood pump
speed (313.2 6 73.7 vs. 264.2 6 60.1 mL/min,
P 5 0.002), which lasted into the last 30 minutes of the
dialysis session (314.4 6 73.9 vs. 262.4 6 59.0 mL/min,
P 5 0.001). Topical anesthetic cream usage was higher in
the study group (88% vs. 47%, P 5 < 0.001), but the
patient reported pain score was no different between the
groups (2.6 6 1.8 vs. 2.1 6 2.0, P 5 0.12). A greater proportion of patients in the study group reported being
“very comfortable” with needle cannulation than those in
control group (94.6% vs. 82%, P 5 0.04). Similar percentages (96% each) of successful cannulations were noted
between the groups.

Fistula outcome at initiation phase
and at 3-month follow-up
At the end of initiation phase, 80% of fistulae in the study
group were in use compared to 50% in the control group
(P 5 0.52). One fistula in the study group and two fistula
in control group were rested due to infiltration. There
were no catheter-related complications including infection, exchanges, or reinsertions during the initiation
phase. One patient in the control group had non-fistula
related hospitalization. At 3 months, 8 fistula were in use
27
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Table 2 Cannulation variables and outcomes

Assessment time (seconds)
Number of attempts
Average blood flow rate
Last recorded blood flow rate
Cannulation time
Pain score
Needle size 17 gauge
16 gauge
15 gauge
Topical anesthetic usage
Successful cannulations
Tourniquet usage
Major infiltration
Minor infiltration
Catheter usage due to infiltration
Patient comfort
Very comfortable
Somewhat comfortable
Neutral
Somewhat uncomfortable

Study (N 5 74)

Control (N 5 51)

P value

101.8 6 80.2
1.0 6 0.1
313.2 6 73.7
314.4 6 73.9
41.1 6 70.6
2.6 6 1.8
30 (40.5%)
21 (28.4%)
23 (31.1%)
60 (88.2%)
71 (96.0%)
74 (100.0%)
5 (6.8%)
2 (2.7%)
5 (6.8%)

22.3 6 22.5
1.0 6 0.2
264.2 6 60.1
262.4 6 59.0
25.0 6 27.9
2.1 6 2.0
25 (49.0%)
17 (33.3%)
9 (17.7%)
22 (46.8%)
48 (96.0%)
49 (98.0%)
2 (4.0%)
3 (6.0%)
2 (3.9%)

<0.001
0.64
0.002
0.001
0.04
0.12
0.24

41 (82.0%)
5 (10.0%)
3 (6.0%)
1 (2.0%)

0.06

70
4
0
0

(94.6%)
(5.4%)
(0.0%)
(0.0%)

with no further infiltration episodes, 3 of them had subsequent procedures, with no hospitalizations or catheterrelated complications. One patient from the study group
had repeat infiltration post-fistula rest and subsequently
the access was abandoned.

DISCUSSION
We report for the first time incorporation of handheld
ultrasound guided cannulation of new AVF by dialysis
technicians is feasible in a busy outpatient hemodialysis.
Preserving a functioning fistula is as important as a successful creation. An avoidable cause of fistula failure is
cannulation error related infiltration. For a long time, the
standard method for cannulating a fistula was the “feel
and stick” method which has seen no major advances.
Advances in portable and hand held ultrasound devices
can aid in improving cannulation success and change the
paradigm of access care in dialysis centers.
Utilization of real-time ultrasound guidance could aid
in visualization of the fistula and minimize cannulation
errors. The requirement of skilled personnel and device
factors like size and cost have precluded widespread use
of ultrasound technology in dialysis access cannulation on
a routine basis. Knowledge of the size and depth of the
target fistula would aid in the choice of needle length and
28

<0.001
0.98
0.40
0.70
0.39
0.70

angle of insertion. Real-time imaging guidance could
potentially minimize cannulation errors. Utilization of a
portable, handheld ultrasound device could provide this
necessary safety practice in dialysis access cannulation.
The Sonic Window device is able to provide the size,
depth at cannulation site and real-time guidance for cannulators. Although time for assessment and cannulation
time were significantly higher in study group, a trend for
greater patient satisfcation with no significant difference
in pain scores. This is likely a reflection of patient perception of safety, which is very valuable in the days of a value
based payment structure. Notably patients in the study
group completed dialysis sessions at higher blood flow
rates possibly indicating optimal needle tip placement
in relation to lumen of the vessel. Although subtle, its
relevance needs to be seen in relation to needle tip
mechanical injury, returning jet of blood shear stress
on the endothelium and its impact on neointimal
hyperplasia.
Infiltrations are less recognized complications of cannulation errors with significant morbidity. The definition
of an “infiltration” related to cannulation is not clear. Lee
et al. used the definition of subcutaneous hematoma
from cannulation precluding fistula use until resolution
of the hematoma.4 The definition of infiltration in our
study was any subcutaneous hematoma noted in access.
Hemodialysis International 2018; 22:23–30
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In practice, not all infiltrations are reported and frequently treated with transient resting of access. Prolongation of
catheter use and delayed therapeutic interventions are
common. Twelve infiltration episodes occurred in 125
cannulations giving an incidence of 9.7%, which is more
than what has been reported in limited published literature. The control group had a fewer number of cannulation counts due to early infiltration despite shorter access
maturation time. The number of subjects may not be
adequate to show a significant decrease in infiltration
rate. Availability of a point of care ultrasound device at
dialysis units can also aid in different methods of cannulations. The two most common cannulations in use are
“site rotation” or “rope ladder” and the “buttonhole”
method. In the most widely used rope ladder method,
puncture sites are successively rotated with the hope that
rotation permits sufficient time for healing.13 Twadorski
described a method based on reuse of the “same” needle
sites subsequently named the “buttonhole” technique.14
Compared to rope ladder, buttonhole has been associated
with significantly less cannulation pain, easier cannulation, and reduced cannulation attempts.15 Widespread
adaptation of the buttonhole technique has been limited
due to difficulty in developing a needle track and
frequent track-related infection. Limited availability of
skilled cannulators adds to the complexity. Having a simple handheld ultrasound device with guidance for needle
insertion will greatly enhance the ability to develop
needle tracks. Further studies are needed to evaluate if
utilization of a handheld ultrasound device would aid in
buttonhole cannulation.
Our study has many limitations. Even though this is a
pilot study, small number of subjects limits its potential.
Crossover of cannulators between groups may have
introduced bias although it’s pragmatic considering
dialysis units to have limited skilled cannulators. We
also feel attentiveness of standard group cannulators
improved in the presence of study personnel. Despite
limitations in this study, we believe ultrasound guidance would greatly enhance the ability to identify fistula
at risk for cannulation failure and minimize cannulation
related complications.
Lack of infiltration data from larger databases impedes
developing safer cannulation practices and evaluation of
economic impact from preventable errors. A large prospective interventional trial evaluating cannulation practices is sorely needed.
In conclusion, our pilot study results show handheld
ultrasound guidance is feasible without enhanced cannulation errors. Portable ultrasound devices like Sonic Window
can be useful aids to incorporate within normal dialysis
Hemodialysis International 2018; 22:23–30

workflow.Larger randomized study with adequate power
and sample size are needed to decisively demonstrate this
intervention and will lead to improved VA outcomes.
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